MX348568B - Compuestos para inhibir la progresión mitótica. - Google Patents
Compuestos para inhibir la progresión mitótica.Info
- Publication number
- MX348568B MX348568B MX2012011396A MX2012011396A MX348568B MX 348568 B MX348568 B MX 348568B MX 2012011396 A MX2012011396 A MX 2012011396A MX 2012011396 A MX2012011396 A MX 2012011396A MX 348568 B MX348568 B MX 348568B
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- mitotic progression
- inhibiting mitotic
- inhibiting
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a compuestos y métodos para el tratamiento del cáncer. En particular, la invención proporciona inhibidores potentes de la cinasa Aurora, composiciones farmacéuticas que comprenden los compuestos, y métodos de uso de los compuestos para el tratamiento del cáncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85934006P | 2006-11-16 | 2006-11-16 | |
PCT/US2007/023948 WO2008063525A1 (en) | 2006-11-16 | 2007-11-14 | Compounds for inhibiting mitotic progression |
Publications (1)
Publication Number | Publication Date |
---|---|
MX348568B true MX348568B (es) | 2017-06-20 |
Family
ID=39315133
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012011398A MX343391B (es) | 2006-11-16 | 2007-11-14 | Proceso para la preparación de 5h-pirimido[5,4-d]benzazepina. |
MX2012011396A MX348568B (es) | 2006-11-16 | 2007-11-14 | Compuestos para inhibir la progresión mitótica. |
MX2009004670A MX2009004670A (es) | 2006-11-16 | 2007-11-14 | Compuestos para inhibir la progresion mitotica. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012011398A MX343391B (es) | 2006-11-16 | 2007-11-14 | Proceso para la preparación de 5h-pirimido[5,4-d]benzazepina. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009004670A MX2009004670A (es) | 2006-11-16 | 2007-11-14 | Compuestos para inhibir la progresion mitotica. |
Country Status (35)
Country | Link |
---|---|
US (6) | US8026246B2 (es) |
EP (4) | EP2497772B1 (es) |
JP (3) | JP5102839B2 (es) |
KR (2) | KR101110458B1 (es) |
CN (2) | CN101547924B (es) |
AR (1) | AR064246A1 (es) |
AT (1) | ATE556076T1 (es) |
AU (1) | AU2007322046B2 (es) |
BR (1) | BRPI0718803B8 (es) |
CA (1) | CA2669680C (es) |
CL (1) | CL2007003244A1 (es) |
CR (3) | CR10782A (es) |
CY (1) | CY1112828T1 (es) |
DK (2) | DK2086981T3 (es) |
EA (1) | EA015779B1 (es) |
ES (3) | ES2537451T3 (es) |
GE (1) | GEP20125459B (es) |
HK (4) | HK1134672A1 (es) |
HR (2) | HRP20120490T1 (es) |
IL (1) | IL198690A0 (es) |
MA (1) | MA30988B1 (es) |
MX (3) | MX343391B (es) |
MY (1) | MY153243A (es) |
NO (1) | NO343338B1 (es) |
NZ (3) | NZ577042A (es) |
PH (1) | PH12012502057B1 (es) |
PL (2) | PL2086981T3 (es) |
PT (2) | PT2497772E (es) |
RS (2) | RS53788B1 (es) |
SG (2) | SG176443A1 (es) |
SI (2) | SI2497772T1 (es) |
TW (1) | TWI401255B (es) |
UA (1) | UA94129C2 (es) |
WO (1) | WO2008063525A1 (es) |
ZA (1) | ZA200903279B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104193750B (zh) | 2004-05-14 | 2018-04-27 | 千禧药品公司 | 通过抑制极光激酶抑制有丝分裂的化合物和方法 |
CL2007003244A1 (es) | 2006-11-16 | 2008-04-04 | Millennium Pharm Inc | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. |
EP2373657B1 (en) * | 2008-12-05 | 2016-09-14 | Millennium Pharmaceuticals, Inc. | 5,7-dihydro-6h-pyrimido[5,4-d][1]benzazepin-6-thiones as plk inhibitors |
CN102264368B (zh) | 2008-12-22 | 2014-09-10 | 米伦纽姆医药公司 | 极光激酶抑制剂与抗cd20抗体的组合 |
JO3635B1 (ar) | 2009-05-18 | 2020-08-27 | Millennium Pharm Inc | مركبات صيدلانية صلبة وطرق لانتاجها |
JO3434B1 (ar) * | 2009-07-31 | 2019-10-20 | Millennium Pharm Inc | مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري |
WO2011103089A1 (en) | 2010-02-19 | 2011-08-25 | Millennium Pharmaceuticals, Inc. | Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate |
US20120107304A1 (en) | 2010-04-27 | 2012-05-03 | Boehringer Ingelheim International Gmbh | Combination therapy in treatment of oncological and fibrotic diseases |
US9085582B2 (en) * | 2010-06-22 | 2015-07-21 | Glaxosmithkline Llc | Benzotriazolodiazepine compounds inhibitors of bromodomains |
TW201316991A (zh) | 2011-06-03 | 2013-05-01 | Millennium Pharm Inc | Mek抑制劑與奧諾拉(aurora)a激酶選擇性抑制劑之組合 |
US20130303519A1 (en) * | 2012-03-20 | 2013-11-14 | Millennium Pharmaceuticals, Inc. | Methods of treating cancer using aurora kinase inhibitors |
CN103772391A (zh) * | 2012-10-23 | 2014-05-07 | 杨子娇 | 一类治疗房角狭窄的化合物及其用途 |
US9724354B2 (en) | 2013-03-22 | 2017-08-08 | Millennium Pharmaceuticals, Inc. | Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinase |
US10335494B2 (en) | 2013-12-06 | 2019-07-02 | Millennium Pharmaceuticals, Inc. | Combination of aurora kinase inhibitors and anti-CD30 antibodies |
EP3236948A4 (en) * | 2014-12-23 | 2018-10-03 | Millennium Pharmaceuticals, Inc. | Combination of raf inhibitors and aurora kinase inhibitors |
JP2018524292A (ja) | 2015-07-21 | 2018-08-30 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | オーロラキナーゼインヒビターと化学療法剤の投与 |
CN108349943A (zh) | 2015-09-09 | 2018-07-31 | 西奈山伊坎医学院 | 杂环受限三环磺酰胺作为抗癌试剂 |
EP3347355B1 (en) | 2015-09-09 | 2022-07-13 | Icahn School of Medicine at Mount Sinai | Heterotricyclic sulfonamides as anti-cancer agents |
JP6591036B2 (ja) | 2016-02-26 | 2019-10-16 | 公益財団法人がん研究会 | Hp1の機能に着目した抗癌剤のスクリーニング方法及び評価系 |
SG10201913331VA (en) | 2016-03-15 | 2020-03-30 | Oryzon Genomics Sa | Combinations of lsd1 inhibitors for use in the treatment of solid tumors |
JP6188986B1 (ja) * | 2017-03-23 | 2017-08-30 | 株式会社ノエビア | 時計遺伝子発現量調整剤及びエラスチン産生促進剤 |
WO2019195658A1 (en) | 2018-04-05 | 2019-10-10 | Dana-Farber Cancer Institute, Inc. | Sting levels as a biomarker for cancer immunotherapy |
WO2020049208A1 (es) | 2018-09-09 | 2020-03-12 | Fundacio Privada Institut De Recerca De La Sida - Caixa | Aurora cinasa como diana para tratar, prevenir o curar una infección por vih o sida |
WO2021041532A1 (en) | 2019-08-26 | 2021-03-04 | Dana-Farber Cancer Institute, Inc. | Use of heparin to promote type 1 interferon signaling |
WO2023196959A1 (en) | 2022-04-07 | 2023-10-12 | Eli Lilly And Company | Process for making a kras g12c inhibitor |
WO2023196887A1 (en) | 2022-04-08 | 2023-10-12 | Eli Lilly And Company | Method of treatment including kras g12c inhibitors and aurora a inhibitors |
US20240108618A1 (en) | 2022-06-30 | 2024-04-04 | Eli Lilly And Company | Kras g12c inhibitor dosing regimens |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4099012A (en) | 1975-08-28 | 1978-07-04 | Ciba-Geigy Corporation | 2-pyrazolyl-benzophenones |
SU1181547A3 (ru) | 1979-02-07 | 1985-09-23 | Ф.Хоффманн-Ля Рош Унд Ко,Аг (Фирма) | Способ получени пиримидо-2-бензазепинов или их фармакологически совместимых кислотно-аддитивных солей (и его вариант) |
US4481142A (en) | 1979-02-07 | 1984-11-06 | Hoffmann-La Roche Inc. | Pyrimido-2-benzazepines |
US4469633A (en) | 1980-05-16 | 1984-09-04 | Hoffmann-La Roche Inc. | N-oxides of 5-oxo-1-phenyl-2-benzazepines |
EP0273697A3 (en) | 1986-12-30 | 1989-11-29 | Merck & Co. Inc. | 2-benzazepines with 5- and 6- membered heterocyclic rings |
US5166151A (en) | 1988-03-25 | 1992-11-24 | Merck & Co., Inc. | 2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof |
US5210082A (en) | 1991-05-16 | 1993-05-11 | Merck & Co., Inc. | 2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders |
GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
JP2000506160A (ja) | 1996-03-08 | 2000-05-23 | ゼネカ リミテッド | 神経学的に活性な試剤としてのアゾロベンズアゼピン誘導体 |
AU5330698A (en) | 1996-12-23 | 1998-07-17 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
GB9713087D0 (en) | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
CA2305307C (en) | 1997-09-29 | 2004-11-30 | Meiji Seika Kaisha, Ltd. | Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
US6277844B1 (en) | 1998-09-14 | 2001-08-21 | Sydney Spector | Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis |
AU4841700A (en) | 1999-05-12 | 2000-11-21 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
WO2001042199A1 (fr) | 1999-12-06 | 2001-06-14 | Ajinomoto Co.,Inc. | Derive de l'acide amidinophenylpyruvique |
CN102250071A (zh) | 2000-12-21 | 2011-11-23 | 沃泰克斯药物股份有限公司 | 可用作蛋白激酶抑制剂的吡唑化合物 |
US6686352B2 (en) | 2001-05-18 | 2004-02-03 | Hoffmann-La Roche Inc. | Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives |
DE10135457A1 (de) * | 2001-07-20 | 2003-02-06 | Adc Automotive Dist Control | Optische Sensoranordnung |
CN100418955C (zh) | 2001-08-09 | 2008-09-17 | 埃科特莱茵药品有限公司 | 新型苯并稠杂环 |
CN1897950A (zh) | 2003-10-14 | 2007-01-17 | 惠氏公司 | 稠合芳基和杂芳基衍生物及其使用方法 |
CN104193750B (zh) | 2004-05-14 | 2018-04-27 | 千禧药品公司 | 通过抑制极光激酶抑制有丝分裂的化合物和方法 |
CN101084214A (zh) | 2004-11-17 | 2007-12-05 | 迈卡纳治疗股份有限公司 | 激酶抑制剂 |
JP2008526723A (ja) | 2004-12-30 | 2008-07-24 | アステックス、セラピューティックス、リミテッド | Cdk、gsk及びオーロラキナーゼの活性を調節するピラゾール誘導体 |
WO2007076348A2 (en) | 2005-12-23 | 2007-07-05 | Smithkline Beecham Corporation | Azaindole inhibitors of aurora kinases |
WO2008021038A2 (en) | 2006-08-09 | 2008-02-21 | Millennium Pharmaceuticals, Inc. | Pyridobenzazepine compounds and methods for inhibiting mitotic progression |
CL2007003244A1 (es) | 2006-11-16 | 2008-04-04 | Millennium Pharm Inc | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. |
JO3635B1 (ar) | 2009-05-18 | 2020-08-27 | Millennium Pharm Inc | مركبات صيدلانية صلبة وطرق لانتاجها |
-
2007
- 2007-11-09 CL CL200703244A patent/CL2007003244A1/es unknown
- 2007-11-14 SI SI200731591T patent/SI2497772T1/sl unknown
- 2007-11-14 BR BRPI0718803A patent/BRPI0718803B8/pt active IP Right Grant
- 2007-11-14 EP EP12153131.3A patent/EP2497772B1/en active Active
- 2007-11-14 MX MX2012011398A patent/MX343391B/es unknown
- 2007-11-14 PT PT121531313T patent/PT2497772E/pt unknown
- 2007-11-14 ES ES12153134.7T patent/ES2537451T3/es active Active
- 2007-11-14 SI SI200730975T patent/SI2086981T1/sl unknown
- 2007-11-14 EP EP15155821.0A patent/EP2944639B1/en active Active
- 2007-11-14 SG SG2011080652A patent/SG176443A1/en unknown
- 2007-11-14 KR KR1020097012501A patent/KR101110458B1/ko active IP Right Grant
- 2007-11-14 AU AU2007322046A patent/AU2007322046B2/en active Active
- 2007-11-14 KR KR1020117022355A patent/KR101342014B1/ko active IP Right Grant
- 2007-11-14 CN CN2007800423837A patent/CN101547924B/zh active Active
- 2007-11-14 ES ES07867449T patent/ES2384123T3/es active Active
- 2007-11-14 EP EP07867449A patent/EP2086981B1/en active Active
- 2007-11-14 NZ NZ577042A patent/NZ577042A/en unknown
- 2007-11-14 DK DK07867449.6T patent/DK2086981T3/da active
- 2007-11-14 NZ NZ597252A patent/NZ597252A/xx unknown
- 2007-11-14 MX MX2012011396A patent/MX348568B/es unknown
- 2007-11-14 DK DK12153131.3T patent/DK2497772T3/en active
- 2007-11-14 PL PL07867449T patent/PL2086981T3/pl unknown
- 2007-11-14 UA UAA200906211A patent/UA94129C2/ru unknown
- 2007-11-14 PT PT07867449T patent/PT2086981E/pt unknown
- 2007-11-14 NZ NZ611898A patent/NZ611898A/en not_active IP Right Cessation
- 2007-11-14 RS RS20150047A patent/RS53788B1/en unknown
- 2007-11-14 CN CN201310367332.9A patent/CN103483343B/zh active Active
- 2007-11-14 SG SG10201503350TA patent/SG10201503350TA/en unknown
- 2007-11-14 JP JP2009537199A patent/JP5102839B2/ja active Active
- 2007-11-14 GE GEAP200711309A patent/GEP20125459B/en unknown
- 2007-11-14 US US11/985,277 patent/US8026246B2/en active Active
- 2007-11-14 AT AT07867449T patent/ATE556076T1/de active
- 2007-11-14 WO PCT/US2007/023948 patent/WO2008063525A1/en active Application Filing
- 2007-11-14 ES ES12153131.3T patent/ES2528793T3/es active Active
- 2007-11-14 EP EP12153134.7A patent/EP2497773B1/en active Active
- 2007-11-14 ZA ZA200903279A patent/ZA200903279B/xx unknown
- 2007-11-14 RS RS20120247A patent/RS52313B/en unknown
- 2007-11-14 TW TW096143087A patent/TWI401255B/zh active
- 2007-11-14 EA EA200970486A patent/EA015779B1/ru unknown
- 2007-11-14 PL PL12153131T patent/PL2497772T3/pl unknown
- 2007-11-14 MY MYPI20091846A patent/MY153243A/en unknown
- 2007-11-14 MX MX2009004670A patent/MX2009004670A/es active IP Right Grant
- 2007-11-14 CA CA2669680A patent/CA2669680C/en active Active
- 2007-11-16 AR ARP070105104A patent/AR064246A1/es unknown
-
2009
- 2009-05-08 CR CR10782A patent/CR10782A/es unknown
- 2009-05-11 IL IL198690A patent/IL198690A0/en active IP Right Grant
- 2009-05-13 NO NO20091864A patent/NO343338B1/no unknown
- 2009-06-12 MA MA31985A patent/MA30988B1/fr unknown
-
2010
- 2010-02-11 HK HK10101590.0A patent/HK1134672A1/xx unknown
-
2011
- 2011-08-25 US US13/217,729 patent/US9988384B2/en active Active
- 2011-08-25 US US13/217,659 patent/US20110312942A1/en not_active Abandoned
- 2011-08-30 JP JP2011187930A patent/JP5452811B2/ja active Active
-
2012
- 2012-06-06 CY CY20121100518T patent/CY1112828T1/el unknown
- 2012-06-12 HR HRP20120490TT patent/HRP20120490T1/hr unknown
- 2012-10-12 PH PH12012502057A patent/PH12012502057B1/en unknown
-
2013
- 2013-03-08 HK HK13102944.8A patent/HK1175777A1/xx unknown
- 2013-03-11 HK HK13102986.7A patent/HK1175778A1/xx unknown
- 2013-11-15 JP JP2013236439A patent/JP2014055166A/ja active Pending
-
2014
- 2014-04-04 CR CR20140154A patent/CR20140154A/es unknown
- 2014-10-15 US US14/514,687 patent/US9765076B2/en active Active
- 2014-11-27 CR CR20140544A patent/CR20140544A/es unknown
-
2015
- 2015-01-13 HR HRP20150047TT patent/HRP20150047T1/hr unknown
-
2016
- 2016-05-17 HK HK16105677.1A patent/HK1217699A1/zh unknown
-
2018
- 2018-06-01 US US15/996,166 patent/US10836766B2/en active Active
-
2020
- 2020-11-16 US US17/099,266 patent/US11958855B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12012502057A1 (en) | Compounds for inhibiting mitotic progression | |
MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
WO2008021038A3 (en) | Pyridobenzazepine compounds and methods for inhibiting mitotic progression | |
WO2006123113A3 (en) | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors | |
WO2007095124A3 (en) | Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors | |
MY148634A (en) | Pyridazinone derivatives | |
TW200604192A (en) | Compounds and methods for inhibiting mitotic progression | |
MX2012000709A (es) | Inhibidores de pirrolopiridina de cinasas. | |
WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
SG179418A1 (en) | Inhibitors of the hedgehog pathway | |
TW200800963A (en) | Chemical compounds | |
HK1113352A1 (en) | Chemical compounds | |
HK1114375A1 (en) | Chemical compounds | |
NZ577916A (en) | Cyclopamine analogs | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
TN2009000049A1 (en) | A pyrrolopyrazin as syk-kinase inhibitor | |
MX2010002210A (es) | Derivados de catecolamina y profarmacos de los mismos. | |
MX2009004140A (es) | Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa 3. | |
MX2009011059A (es) | Aminopirimidinas utiles como inhibidores de cinasas. | |
MX2010003563A (es) | Inhibidores de proteina cinasa de c-met. | |
WO2010039668A3 (en) | Inhibitors of cyclin kinase inhibitor p21 | |
EP2083806A4 (en) | USE OF AN ANTI-CANCER COMPOUND | |
MX2009012079A (es) | Compuestos heterociclicos condensados como inhibidores de proteina cinasas. | |
UA93198C2 (ru) | Производные пиразола, способ их получения, их применения, фармацевтическая композиция (варианты) и способ лечения злокачественного новообразования (варианты) | |
UA95260C2 (ru) | Производное 4-(3-аминопиразол)пиримидина и его применение для лечения злокачественного новообразования |